$GENI

Genius Sports Ltd

AlphAI earnings readQ2 FY2026 · AUG 6Genius Sports Beats Second Quarter Guidance and Raises Full-Year OutlookVerdict: strong

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

No enriched coverage for $GENI in the last 7 days.

No SEC Form 4 filings for $GENI in the last 30 days.

See all $GENI insider activity →

Cathie Wood’s ARK sells Robinhood stock, buys CoreWeave and Kratos

ARK ETFs bought CoreWeave (CRWV) and Kratos (KTOS) for $19.68M and $9.15M, respectively, and sold Robinhood (HOOD) and Personalis (PSNL) for $17.01M and $12.01M. Other trades included Teradyne (TER), Recursion (RXRX), and smaller positions in several other companies.

Genius, CF, 3M, Nike, Synopsys Trending With Analysts

Analysts cover five stocks: Genius Sports (GENI) with a $8 target, CF Industries (CF) with a $162 target, 3M (MMM) upgraded to Hold with a $171 target, Nike (NKE) downgraded to Sell with a $30 target, and Synopsys (SNPS) upgraded to Buy with a $700 target. Analysts cite growth, valuation, and market conditions as key factors.

GENI sentiment & insider activity

Recent GENI coverage spans financial news, earnings and insider activity.

What's driving GENI

AlphAI scores every news story that mentions GENI with an AI model for sentiment and relevance, and aggregates insider trades from Genius Sports Ltd's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $GENI

Score
$GENIMed

Genius, CF, 3M, Nike, Synopsys Trending With Analysts

Analysts cover five stocks: Genius Sports (GENI) with a $8 target, CF Industries (CF) with a $162 target, 3M (MMM) upgraded to Hold with a $171 target, Nike (NKE) downgraded to Sell with a $30 target, and Synopsys (SNPS) upgraded to Buy with a $700 target. Analysts cite growth, valuation, and market conditions as key factors.

$JCILow

Here are Friday's biggest analyst calls: Nvidia, SpaceX, Apple, Tesla, Meta, AMD, BP, Costco, Nike & more

Analysts made multiple rating changes: Wells Fargo initiated Johnson Controls (JCI) as overweight, UBS initiated Chemed (CHE) as buy, Mizuho reiterated SpaceX as outperform, Barclays initiated Ligand Pharmaceuticals (LGND) as overweight, Seaport reiterated Nvidia (NVDA) as sell, UBS upgraded Stem (STEM) to buy, HSBC upgraded BP (BP) to buy, Bernstein initiated CF Industries (CF) as outperform, Bank of America reiterated AMD (AMD) as buy, Bernstein reiterated Apple (AAPL) as outperform, JPMorgan…

$GENIMedAI 8/10

Why Genius Sports Popped by Almost 10% This Week

Genius Sports (NYSE: GEN) rose nearly 10% over the week after its Q2 results beat revenue expectations and the company raised 2026 guidance. Revenue was $196M versus $185M guidance and just under consensus. Net loss widened to about $77M ($0.28/share). Full-year revenue guidance increased to about $1.03B and adjusted EBITDA to $285M-$295M.

Genius Sports Builds Prediction Market Foundation with Kalshi and Polymarket Official Data Agreements

Genius Sports said it signed official sports data agreements with Kalshi and Polymarket to support prediction market contract settlement, plus information sharing and integrity services with market-type restrictions. CEO Mark Locke discussed the deals on a Q2 earnings call. Genius reported Q2 group revenue of $195.5M (+65% YoY) and raised full-year guidance to $1.02B revenue and $290M adjusted EBITDA.

Related tickers